
Shanmuga Hospital Limited - IPO
SMEShanmuga Hospital Stock Price

Shanmuga Hospital IPO Details
Shanmuga Hospital IPO Subscription
Shanmuga Hospital IPO Application Wise Breakup
Shanmuga Hospital IPO Dates
- 13 Feb 2025Opening dateOPD
- 17 Feb 2025Closing dateCOD
- 18 Feb 2025Basis of AllotmentBOA
- 19 Feb 2025Initiation of RefundsIOR
- 19 Feb 2025Credit of SharesCOS
- 20 Feb 2025Listing dateLID
Shanmuga Hospital IPO Lot Size
Application | Lots | Shares | Amount |
---|---|---|---|
Retain Minimum | 1 | 2000 | ₹108,000 |
Retain Maximum | 1 | 2000 | ₹108,000 |
HNI Minimum | 2 | 4000 | ₹216,000 |
Shanmuga Hospital IPO Reservation
Promoter Holding
Documents
Shanmuga Hospital IPO Valuations
Shanmuga Hospital Limited Financial Information
Period Ended | 30 Sep 2024 | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 | ||||||||||||||||||||||||||||||||||||
Assets | 36.53 | 33.92 | 23.05 | 10.65 | ||||||||||||||||||||||||||||||||||||
Revenue | 24.83 | 43.39 | 39.5 | 41.47 | ||||||||||||||||||||||||||||||||||||
Profit After Tax | 2.39 | 5.26 | 4.76 | 6.72 | ||||||||||||||||||||||||||||||||||||
Net Worth | 19.53 | 17.13 | 11.82 | 7.06 | ||||||||||||||||||||||||||||||||||||
Reserves and Surplus | 9.73 | 7.34 | 11.74 | 6.98 | ||||||||||||||||||||||||||||||||||||
Total Borrowing | 9.76 | 9.02 | 7.65 | |||||||||||||||||||||||||||||||||||||
Amount in ₹ Crore |
About Shanmuga Hospital IPO
Incorporated in 2020, Shanmuga Hospital Limited is a Multispecialty Hospital.
Shanmuga Hospital is equipped with advanced healthcare technology and having 151 bed capacity, it addresses the community’s medical needs, serving patients from nearby regions.
Accredited by NABH and NABL, the hospital is dedicated to providing high-quality healthcare services, including prevention, treatment, and rehabilitation.
Located at 51/24 Saradha College Road, Salem, Tamil Nadu, the hospital spans 45,311 square feet across two blocks and three floors, offering IPD and OPD services with a dedicated team.
Hospital Units:
- Shanmuga Pharmacy & Diagnostics:
The hospital operates Shanmuga Pharmacy, providing medications to OPD and IPD patients. Shanmuga Diagnostics offers reliable pathology services for accurate medical evaluations and treatment planning. - Shanmuga Clinics:
The hospital extends services through Shanmuga Clinics, providing specialized consultations and treatments in Salem. Critical patients are transferred to the main hospital for advanced care when necessary.
Services: Oncology, General Surgery, Orthopaedics, Cardiology,General Medicine, Paediatrics & Neonatology, Neurology, Endocrinology & Diabetes Department, Plastic Surgery, Respiratory Medicine.
As on August 31, 2024, the hospital had 72 doctors, out of whom 9 doctors were Resident Doctors, 7 Junior Doctors, 28 Senior Consulting Doctors and 28 Consulting Visiting Doctors.
Competitive Strengths:
- Oncology Presence
- Rich experience of promoters of over four decades
- Cost Affordable to Regional Population
- Specialized Equipment like LINAC, CATHLAB, MRI, MODULAR OT
- Tie-up with Government and Private Insurance Companies
Strength Of Shanmuga Hospital IPO
1. Established and proven track record.
2. Leveraging the experience of our Promoters.
3. Experienced management team and a motivated and efficient work force.
4. Cordial relations with our customers.
5. Quality Assurance & Control.
Risk Of Shanmuga Hospital IPO
1. Our Company, Directors, Promoters and Group Companies are parties to certain legal proceedings. Any adverse decision in such proceedings may have a material adverse effect on our business, results of operations and financial condition
2. Our Company has limited operating history, and therefore investors may not be able to assess our prospects on the basis of historical results.
3. We are highly dependent on our healthcare professionals, including doctors, nurses that we engage on a consultancy basis, and our business and financial results could be impacted if we are not able to attract and retain such healthcare professionals.
4. Our Company is yet to place orders for medical equipment proposed to be installed at our hospital. Any delay in placing orders or procurement of such equipment may delay the schedule of implementation and possibly increase the cost of commencing operations.
5. We generate certain revenues from the arrangements with government sponsored health schemes, any adverse change in these regulations/government policies related to such schemes may adversely affect our business, results of operations, cash flows and prospects.
6. Delay in receipt of payment from our patients / customers may affect our cash flows, which may, in turn affect our financial condition and results of operations.
7. Our indebtedness and the conditions and restrictions imposed by our financing arrangements may limit our ability to grow our business and adversely impact our business.
8. Changes in healthcare laws, rules and regulations may materially adversely affect our business
9. Our Company had negative cash flow in recent fiscals, details of which are given below. Sustained negative cash flow could adversely impact our business, financial condition and results of operations.
10. There are certain instances of delays in the past with ROC/Statutory Authorities.
Objectives Shanmuga Hospital IPO
- Funding Capital Expenditure towards Purchase of additional Medical Equipment
- General Corporate Purposes
Company Contact Details
Shanmuga Hospital Limited
51/24,
Saradha College Road,
Salem, 636007
Phone: +91 427 2706674
Email: cs@smrft.org
Website: http://www.shanmugahospital.com/
Registrar Contact Details
Lead Mangers
Finshore Management Services Limited
Market Maker
Black Fox Financial